A stenosis is an abnormal narrowing in a blood vessel or other tubular organ or structure.
A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.
The COVID-19 crisis is not impacting cardiovascular procedures as heavily as it is other therapy areas, since the majority of these procedures are essential, according to GlobalData, a leading data and analytics company. GlobalData estimates that 96.7% of cardiovascular procedures performed in the US are essential procedures.
Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.
Digitization can do a lot in medicine, even save lives. This is shown by the specific case of an 80-year-old patient in Mainz.
Transcatheter aortic valve replacement is a revolutionary technology for the treatment of patients with severe calcific aortic stenosis.
Using the Canadian Light Source (CLS) at the University of Saskatchewan, Marta Cerruti, an Associate Professor in McGill's Department of Materials Engineering, and her team analyzed damaged heart valves from patients who had undergone transplants.
Patients who underwent transcatheter aortic valve replacement (TAVR) did not have a higher rate of death at one year compared with those who had their heart valve replaced via open-heart surgery, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Transcatheter aortic valve replacement procedures had a high rate of success and low risk of death or disabling stroke at 30 days in patients with a bicuspid, or two-leaflet, aortic valve, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
A breakthrough medical technology can save the lives of children with heart defects. Scientists have developed the first-ever heart valve that grows with the child, reducing the need for risky heart surgeries in the future.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that patients who underwent a minimally invasive transcatheter aortic-valve replacement, had similar key 5-year clinical outcomes of death and stroke as patients who had traditional open-heart surgery to replace the valve.
Undiagnosed chest pain sends 8-10 million Americans to Emergency Departments annually, making it the second most common complaint. Emergency physicians must rapidly identify patients whose chest pain is cardiac-related.
While transcatheter aortic valve replacement (TAVR) continues to expand its pool of eligible patients, open heart surgery- resulting in excellent patient survival and fewer strokes when compared to TAVR- is the best option for young and middle-aged adults with aortic valve disease- at least for now, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In response to continued discussion on the validity of the conclusions of the EXCEL trial comparing coronary stenting to coronary bypass surgery, The American Association for Thoracic Surgery (AATS) has released a statement calling for the release of all trial data to help surgeons and patients make informed choices based on sound analysis.
Research published online today in Journal of the American College of Cardiology, confirms that women who have gestational hypertension or preeclampsia in at least one pregnancy will have higher cardiovascular risk than women without such a history, and that this elevated risk persists at least into their 60s.
Many questions remain about the mechanisms that control blood pressure, particularly in relation to hypertension.
Since August, when the Food and Drug Administration approved a minimally invasive heart valve procedure for an expanded group of patients with aortic stenosis, Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention at Cedars-Sinai, says many more patients are opting for the procedure known as transcatheter aortic valve replacement.
The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.
Patients with left main coronary artery disease (LMCAD) typically have a poor prognosis due to the large amount of myocardium at risk.
The heart pumps blood throughout the body to provide the needed oxygen and nutrients. In the heart, blood flows to get oxygen from the lungs to deliver to the cells. Some of the most important structures in the heart are the valves, because they prevent the backflow of blood, avoiding the mixture of oxygenated blood with the ones that still need to be oxygenated.